Repligen
RGEN
#2574
Rank
HK$52.23 B
Marketcap
HK$927.31
Share price
0.42%
Change (1 day)
-7.26%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of December 2025 : HK$5.40 Billion

According to Repligen 's latest financial reports the company's total debt is HK$5.40 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2025-12-31HK$5.36 B0.76%
2024-12-31HK$5.32 B-4.17%
2023-12-31HK$5.55 B68.22%
2022-12-31HK$3.30 B15.78%
2021-12-31HK$2.85 B33.69%
2020-12-31HK$2.13 B4.11%
2019-12-31HK$2.05 B153.05%
2018-12-31HK$0.81 B4.51%
2017-12-31HK$0.77 B4.96%
2016-12-31HK$0.73 B
2005-03-31HK$0.93 M40.18%
2004-03-31HK$0.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$501.28 B 9,170.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$308.67 B 5,608.40%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$160.62 B 2,870.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$369.44 B 6,732.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.19 B-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$1.95 B-63.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.25 B-39.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$2.75 B-49.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.74 B-12.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$20.14 B 272.55%๐Ÿ‡บ๐Ÿ‡ธ USA